In short, Nooms individualized approach to titration can optimize the riskbenefit tradeoff , which can be especially important for patients at higher risk of discontinuation
Among patients with acute MI undergoing percutaneous interventions, GLP-1 treatment can reduce infarct size, together with improving left ventricular ejection fraction (LVEF) [71]
Semaglutide slows stomach emptying (causing nausea, constipation, or diarrhea), and berberine independently triggers digestive upset, bloating, and cramping
Optical coherence tomography Change in pRNFL thickness was not associated with the treatment group but with pRNFL thickness at baseline (M3: \(\beta\)= 0.32, 95% CI 0.41, 0.23
This lack of supply chain transparency is itself concerning